Global Veterinary Therapeutics Market Size, Share, Production, Growth, Trends, and Forecast 2019-2026

Chapter 1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary
3.1. Global Veterinary Therapeutics: Market Snapshot
3.2. Market Share Analysis by Region, 2018
3.3. Global Veterinary Therapeutics Market : Opportunity Map

Chapter 4. Market Overview
4.1. Product Overview
4.2. Global Veterinary Therapeutics Market : Key Industry Developments
4.3. Global Veterinary Therapeutics Market : Market Indicators

Chapter 5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Demand for High Quality Proteins
5.2.2. Growth in spend on companion animals globally
5.2.3. Increased medical and surgical capabilities for companion animals
5.2.4. Greater emphasis on prevention and wellness by veterinarians and owners
5.2.5. Increase in ownership of companion animals
5.2.6. Evolution of new products combating emergence of new diseases in animals
5.2.7. Development of vaccines and other pharma products to cope up with zoonotic disease concerns
5.3. Restraints
5.3.1. Low R&D returns and aging product portfolio
5.3.2. Stringent regulatory framework
5.3.3. Rising concern about the use of antibiotics and growth promoters in food animals
5.3.4. Prevalence of counterfeit medicines
5.4. Global Veterinary Therapeutics Market : Opportunity Analysis
5.5. Opportunities
5.5.1. Biologics and specialty care offer potential opportunities for players to invest in
5.5.2. Growing awareness and affordability of therapeutics for pets and livestock offer significant opportunity to new entrants
5.6. Key Trends
5.7. Global Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
5.8. Porter's Analysis
5.9. Veterinary Therapeutics Market Outlook

Chapter 6. Veterinary Therapeutics Market Analysis, by Product Type
6.1. Key Findings
6.2. Introduction
6.3. Global Veterinary Therapeutics Market Value Share Analysis, by Product Type
6.4. Veterinary Therapeutics Market Analysis, by Product Type
6.4.1. Drugs
6.4.2. Vaccines
6.4.3. Medicated Feed Additives
6.5. Global Veterinary Drugs Market Analysis, by Drugs Type
6.5.1. Anti-infective
6.5.2. Anti-inflammatory
6.5.3. Parasiticides
6.5.4. Others
6.6. Global Veterinary Vaccines Market Analysis, by Vaccines Type
6.6.1. Inactivated Vaccines
6.6.2. Live Attenuated Vaccines
6.6.3. Recombinant Vaccines
6.6.4. Others
6.7. Global Veterinary Medicated Feed Additives Market Analysis, by Medicated Feed Additives Type
6.7.1. Antibiotics
6.7.2. Amino Acids
6.7.3. Others
6.8. Market Attractiveness Analysis, by Product Type
6.9. Key Trends

Chapter 7. Veterinary Therapeutics Market Analysis, by Animal Type
7.1. Key Findings
7.2. Introduction
7.3. Global Veterinary Therapeutics Market Value Share Analysis, by Animal Type
7.4. Veterinary Therapeutics Market Analysis, by Animal Type
7.4.1. Companion
7.4.2. Livestock
7.5. Market Attractiveness Analysis, by Animal Type
7.6. Key Trends

Chapter 8. Veterinary Therapeutics Market Analysis, by Route of Administration
8.1. Key Findings
8.2. Introduction
8.3. Global Veterinary Therapeutics Market Value Share Analysis, by Route of Administration
8.4. Veterinary Therapeutics Market Analysis, by Route of Administration
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Topical
8.5. Market Attractiveness Analysis, by Route of Administration
8.6. Key Trends

Chapter 9. Veterinary Therapeutics Market Analysis, by Distribution Channel
9.1. Key Findings
9.2. Introduction
9.3. Global Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel
9.4. Veterinary Therapeutics Market Analysis, by Distribution Channel
9.4.1. Veterinary Hospitals
9.4.2. Veterinary Clinics
9.4.3. Pharmacies & Drug stores
9.4.4. Others
9.5. Market Attractiveness Analysis, by Distribution Channel
9.6. Key Trends

Chapter 10. Veterinary Therapeutics Market Analysis, by Region
10.1. Global Veterinary Therapeutics Market Snapshot, by Country
10.2. Global Veterinary Therapeutics Market Value Share Analysis, by Region
10.3. Veterinary Therapeutics Market Forecast, by Region
10.4. Market Attractiveness Analysis, by Region

Chapter 11. North America Veterinary Therapeutics Market Analysis
11.1. Key Findings
11.2. Market Overview
11.3. Market Analysis, by Product
11.3.1. Market Value Share Analysis, by Product
11.3.2. Market Size (US$ Mn) Forecast, by Product
11.3.2.1. Drugs
11.3.2.2. Vaccines
11.3.2.3. Medicated Feed Additives
11.4. Market Analysis, by Animal
11.4.1. Market Value Share Analysis, by Animal
11.4.2. Market Size (US$ Mn) Forecast, by Animal
11.4.2.1. Companion
11.4.2.2. Livestock
11.5. Market Analysis, by Route of Administration
11.5.1. Market Value Share Analysis, by Route of Administration
11.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
11.5.2.1. Oral
11.5.2.2. Parenteral
11.5.2.3. Topical
11.6. Market Analysis, by Distribution Channel
11.6.1. Market Value Share Analysis, by Distribution Channel
11.6.2. Market Size (US$ Mn) Forecast, by Distribution Channel
11.6.2.1. Veterinary Hospitals
11.6.2.2. Veterinary Clinics
11.6.2.3. Pharmacies & Drug stores
11.6.2.4. Others
11.7. Market Analysis, by Country
11.7.1. Market Value Share Analysis, by Country
11.7.2. Market Size (US$ Mn) Forecast, by Country, 2019–2024
11.7.2.1. U.S.
11.7.2.2. Canada
11.8. Market Attractiveness Analysis
11.8.1. by Product
11.8.2. by Animal
11.8.3. by Route of Administration
11.8.4. by Distribution Channel
11.8.5. by Country
11.9. Market Trends

Chapter 12. Europe Veterinary Therapeutics Market Analysis
12.1. Key Findings
12.2. Market Overview
12.3. Market Analysis, by Product
12.3.1. Market Value Share Analysis, by Product
12.3.2. Market Size (US$ Mn) Forecast, by Product
12.3.2.1. Drugs
12.3.2.2. Vaccines
12.3.2.3. Medicated Feed Additives
12.4. Market Analysis, by Animal
12.4.1. Market Value Share Analysis, by Animal
12.4.2. Market Size (US$ Mn) Forecast, by Animal
12.4.2.1. Companion
12.4.2.2. Livestock
12.5. Market Analysis, by Route of Administration
12.5.1. Market Value Share Analysis, by Route of Administration
12.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
12.5.2.1. Oral
12.5.2.2. Parenteral
12.5.2.3. Topical
12.6. Market Analysis, by Distribution Channel
12.6.1. Market Value Share Analysis, by Distribution Channel
12.6.2. Market Size (US$ Mn) Forecast, by Distribution Channel
12.6.2.1. Veterinary Hospitals
12.6.2.2. Veterinary Clinics
12.6.2.3. Pharmacies & Drug stores
12.6.2.4. Others
12.7. Market Analysis, by Country
12.7.1. Market Value Share Analysis, by Country
12.7.2. Market Size (US$ Mn) Forecast, by Country, 2019–2024
12.7.2.1. U.K.
12.7.2.2. Germany
12.7.2.3. Italy
12.7.2.4. France
12.7.2.5. Spain
12.7.2.6. Rest of Europe
12.8. Market Attractiveness Analysis
12.8.1. by Product
12.8.2. by Animal
12.8.3. by Route of Administration
12.8.4. by Distribution Channel
12.8.5. by Country
12.9. Market Trends

Chapter 13. Asia Pacific Veterinary Therapeutics Market Analysis
13.1. Key Findings
13.2. Market Overview
13.3. Market Analysis, by Product
13.3.1. Market Value Share Analysis, by Product
13.3.2. Market Size (US$ Mn) Forecast, by Product
13.3.2.1. Drugs
13.3.2.2. Vaccines
13.3.2.3. Medicated Feed Additives
13.4. Market Analysis, by Animal
13.4.1. Market Value Share Analysis, by Animal
13.4.2. Market Size (US$ Mn) Forecast, by Animal
13.4.2.1. Companion
13.4.2.2. Livestock
13.5. Market Analysis, by Route of Administration
13.5.1. Market Value Share Analysis, by Route of Administration
13.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
13.5.2.1. Oral
13.5.2.2. Parenteral
13.5.2.3. Topical
13.6. Market Analysis, by Distribution Channel
13.6.1. Market Value Share Analysis, by Distribution Channel
13.6.2. Market Size (US$ Mn) Forecast, by Distribution Channel
13.6.2.1. Veterinary Hospitals
13.6.2.2. Veterinary Clinics
13.6.2.3. Pharmacies & Drug stores
13.6.2.4. Others
13.7. Market Analysis, by Country
13.7.1. Market Value Share Analysis, by Country
13.7.2. Market Size (US$ Mn) Forecast, by Country, 2019–2024
13.7.2.1. China
13.7.2.2. Japan
13.7.2.3. India
13.7.2.4. ANZ
13.7.2.5. Rest of APAC
13.8. Market Attractiveness Analysis
13.8.1. by Product
13.8.2. by Animal
13.8.3. by Route of Administration
13.8.4. by Distribution Channel
13.8.5. by Country
13.9. Market Trends

Chapter 14. Latin America Veterinary Therapeutics Market Analysis
14.1. Key Findings
14.2. Market Overview
14.3. Market Analysis, by Product
14.3.1. Market Value Share Analysis, by Product
14.3.2. Market Size (US$ Mn) Forecast, by Product
14.3.2.1. Drugs
14.3.2.2. Vaccines
14.3.2.3. Medicated Feed Additives
14.4. Market Analysis, by Animal
14.4.1. Market Value Share Analysis, by Animal
14.4.2. Market Size (US$ Mn) Forecast, by Animal
14.4.2.1. Companion
14.4.2.2. Livestock
14.5. Market Analysis, by Route of Administration
14.5.1. Market Value Share Analysis, by Route of Administration
14.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
14.5.2.1. Oral
14.5.2.2. Parenteral
14.5.2.3. Topical
14.6. Market Analysis, by Distribution Channel
14.6.1. Market Value Share Analysis, by Distribution Channel
14.6.2. Market Size (US$ Mn) Forecast, by Distribution Channel
14.6.2.1. Veterinary Hospitals
14.6.2.2. Veterinary Clinics
14.6.2.3. Pharmacies & Drug stores
14.6.2.4. Others
14.7. Market Analysis, by Country
14.7.1. Market Value Share Analysis, by Country
14.7.2. Market Size (US$ Mn) Forecast, by Country, 2019–2024
14.7.2.1. Brazil
14.7.2.2. Mexico
14.7.2.3. Rest of LATAM
14.8. Market Attractiveness Analysis
14.8.1. by Product
14.8.2. by Animal
14.8.3. by Route of Administration
14.8.4. by Distribution Channel
14.8.5. by Country
14.9. Market Trends

Chapter 15. Middle East & Africa Veterinary Therapeutics Market Analysis
15.1. Key Findings
15.2. Market Overview
15.3. Market Analysis, by Product
15.3.1. Market Value Share Analysis, by Product
15.3.2. Market Size (US$ Mn) Forecast, by Product
15.3.2.1. Drugs
15.3.2.2. Vaccines
15.3.2.3. Medicated Feed Additives
15.4. Market Analysis, by Animal
15.4.1. Market Value Share Analysis, by Animal
15.4.2. Market Size (US$ Mn) Forecast, by Animal
15.4.2.1. Companion
15.4.2.2. Livestock
15.5. Market Analysis, by Route of Administration
15.5.1. Market Value Share Analysis, by Route of Administration
15.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
15.5.2.1. Oral
15.5.2.2. Parenteral
15.5.2.3. Topical
15.6. Market Analysis, by Distribution Channel
15.6.1. Market Value Share Analysis, by Distribution Channel
15.6.2. Market Size (US$ Mn) Forecast, by Distribution Channel
15.6.2.1. Veterinary Hospitals
15.6.2.2. Veterinary Clinics
15.6.2.3. Pharmacies & Drug stores
15.6.2.4. Others
15.7. Market Analysis, by Country
15.7.1. Market Value Share Analysis, by Country
15.7.2. Market Size (US$ Mn) Forecast, by Country, 2019–2024
15.7.2.1. South Africa
15.7.2.2. Saudi Arabia
15.7.2.3. UAE
15.7.2.4. Rest of MEA
15.8. Market Attractiveness Analysis
15.8.1. by Product
15.8.2. by Animal
15.8.3. by Route of Administration
15.8.4. by Distribution Channel
15.8.5. by Country
15.9. Market Trends

Chapter 16. Company Profiles
16.1. Veterinary Therapeutics Market Share Analysis, by Company (2018)
16.2. Competition Matrix
16.3. Company Profiles
16.3.1. Bayer AG
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Boehringer Ingelheim GmbH
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Financial Overview
16.3.2.3. Product Portfolio
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Ceva Santé Animale
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Financial Overview
16.3.3.3. Product Portfolio
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Dechra Pharmaceuticals PLC
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Financial Overview
16.3.4.3. Product Portfolio
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Eli Lilly and Company (Elanco Animal Health)
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Financial Overview
16.3.5.3. Product Portfolio
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Merck Animal Health
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Financial Overview
16.3.6.3. Product Portfolio
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Sanofi (Merial Animal Health)
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Financial Overview
16.3.7.3. Product Portfolio
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Virbac
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Financial Overview
16.3.8.3. Product Portfolio
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Vetoquinol S.A.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Financial Overview
16.3.9.3. Product Portfolio
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Zoetis, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Financial Overview
16.3.10.3. Product Portfolio
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview